Business Description
Puma Biotechnology is a Los Angeles-based company founded in 2010 that develops and sells cancer treatments in the United States and around the world. Its main product, NERLYNX, is a pill used to treat certain types of HER2-positive breast cancer, while its pipeline includes a compound targeting several other cancers such as lung and head and neck cancer. The company distributes its products through specialty pharmacies and works with a range of partners globally, including Pfizer and several regional licensees, to bring its treatments to patients.
